Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: A new approach to optimize a syngeneic, orthotopic, murine bladder cancer model

BJU International

Volumn 101, Issue 1, 2008, Pages 120-124

  Jurczok, Andreas ^a   Fornara, Paolo ^a   Söling, Ariane ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Bioluminescence imaging; Bladder cancer; Cell adhesion; Integrins; Oligopeptides

Indexed keywords

CELL ADHESION MOLECULE; GLUTAMYLISOLEUCYLLEUCYLASPARTYLVALINE; GLYCYLARGINYLGLYCYLASPARTYLSERINE; INTEGRIN RECEPTOR; LUCIFERASE; OLIGOPEPTIDE; PARAFFIN; RECEPTOR BLOCKING AGENT; TYROSYLISOLEUCYLGLYCYLSERYLARGININE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BLADDER CANCER; BLADDER INJURY; BLADDER SURGERY; BLADDER WALL; CANCER CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER MODEL; CANCER PREVENTION; CANCER STAGING; CELL ADHESION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFICACY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY ANALYSIS; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; CASE-CONTROL STUDIES; CELL ADHESION; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; MICE; OLIGOPEPTIDES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 36849088621     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07193.x     Document Type: Article

References (26)

1. Hisataki T, Miyao N, Masumori N et al. Risk factors for multiple intravesical recurrences of superficial bladder cancer. Urology 2001 58 : 935 9
2. Akagashi K, Tanda H, Kato S et al. Recurrence pattern for superficial bladder cancer. Int J Urol 2006 13 : 686 91
3. Langbein S, Hacker A, Badawi JK, Michel MS, Alken P. [Early instillation in superficial bladder carcinoma. Current status]. Urologe A 2004 43 : 1531 6
4. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984 309 : 30 3
5. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996 12 : 697 715
6. Jost SP, Gosling JA, Dixon JS. The morphology of normal human bladder urothelium. J Anat 1989 167 : 103 15
7. Bohle A, Jurczok A, Ardelt P et al. Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J Urol 2002 167 : 357 63
8. Aumailley M, Gerl M, Sonnenberg A, Deutzmann R, Timpl R. Identification of the Arg-Gly-Asp sequence in laminin A chain as a latent cell-binding site being exposed in fragment P1. FEBS Lett 1990 262 : 82 6
9. Pfaff M, Aumailley M, Specks U, Knolle J, Zerwes HG, Timpl R. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. Exp Cell Res 1993 206 : 167 76
10. Litynska A, Przybylo M, Pochec E, Laidler P. Adhesion properties of human bladder cell lines with extracellular matrix components: the role of integrins and glycosylation. Acta Biochim Pol 2002 49 : 643 50
11. Graf J, Ogle RC, Robey FA et al. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor. Biochemistry 1987 26 : 6896 900
12. Soling A, Theiss C, Jungmichel S, Rainov NG. A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet Vaccines Ther 2004 2 : 7
13. Iwamoto Y, Robey FA, Graf J et al. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987 238 : 1132 4
14. Lee SY, Wang Z, Lin CK et al. Regulation of intestine-specific spatiotemporal expression by the rat lactase promoter. J Biol Chem 2002 277 : 13099 105
15. Gardiner RA, Seymour GJ, Lavin MF, Strutton GM, Gemmell E, Hazan G. Immunohistochemical analysis of the human bladder. Br J Urol 1986 58 : 19 25
16. See WA, Rohlf DP, Crist SA. In vitro particulate adherence to fibronectin. correlation with in vivo particulate adherence to sites of bladder injury. J Urol 1992 147 : 1416 23
17. Hyacinthe LM, Jarrett TW, Gordon CS, Vaughan ED, Whalen GF. Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS). Ann Surg Oncol 1995 2 : 450 6
18. Yamamoto S, Kaneda Y, Okada N et al. Antimetastatic effects of synthetic peptides containing the core sequence of the type III connecting segment domain (IIICS) of fibronectin. Anticancer Drugs 1994 5 : 424 8
19. Singleton C, Menino AR. Effects of inhibitors of integrin binding on cellular outgrowth from bovine inner cell masses in vitro. In Vitro Cell Dev Biol Anim 2005 41 : 29 37
20. Matsuoka T, Hirakawa K, Chung YS et al. Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer. Clin Exp Metastasis 1998 16 : 381 8
21. Günther JH, Jurczok A, Wulf T et al. Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 1999 59 : 2834 7
22. Colin M, Moritz S, Schneider H, Capeau J, Coutelle C, Brahimi-Horn MC. Haemoglobin interferes with the ex vivo luciferase luminescence assay: consequence for detection of luciferase reporter gene expression in vivo. Gene Ther 2000 7 : 1333 6
23. Nogawa M, Yuasa T, Kimura S et al. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest 2005 115 : 978 85
24. Sato K, Yuasa T, Nogawa M et al. A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer 2006 95 : 1354 61
25. Smakman N, Schaap N, Snijckers CM, Borel RI, Kranenburg O. NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation. Urology 2005 66 : 434 40
26. Gildea JJ, Golden WL, Harding MA, Theodorescu D. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer. Genes Chromosomes Cancer 2000 27 : 252 63